July 2, 2021
¾«¶«Ó°Òµhas been supporting the Pacific Program to Eliminate Lymphatic Filariasis (PacELF) of World Health Organization (WHO) in collaboration with Japan International Cooperation Agency (JICA) since 2013. ¾«¶«Ó°Òµhas provided approximately 10.4 million DEC tablets, a treatment for lymphatic filariasis, to Papua New Guinea.
Mass drug administration (MDA) of lymphatic filariasis treatment in Papua New Guinea has been postponed due to the COVID-19. In collaboration with JICA, ¾«¶«Ó°Òµdonated 50,000 masks and 35,000 gloves for the COVID-19 countermeasures in resuming MDA in Papua New Guinea. Eisai's support for MDA was featured in Papua New Guinea’s national newspaper "".
The DEC tablets provided by ¾«¶«Ó°Òµin collaboration with JICA have been used in MDA in New Ireland (2014-2018) and East New Britain (2019-present) in Papua New Guinea. From this fiscal year, Eisai's DEC tablets will also be used in MDA in West New Britain.
¾«¶«Ó°Òµwill keep working on lymphatic filariasis elimination through many activities in addition to the free provision of DEC tablets.
Share